Integrating Biology for Safe Intensification of Glioblastoma Hypofractionated Treatment on the MR-Linac
Clinical trial NCT07457307 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07457307
- Sponsor
- NYU Langone Health
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2028-06-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.